Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis

NCT02701205 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis
Psoriasis

Interventions

BIOLOGICAL: etanercept
BIOLOGICAL: etanercept (half dose)
DRUG: placebo

Sponsor

Shanghai Celgen Bio-Pharmaceutical Co.,Ltd